SCHEMBL5578

SCHEMBL5578

CC[C@]1(O)CC[C@@]2(CCN(c3ccc(CC(F)(F)F)cc3)C2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 1/20 0.34
CYP3A4 P08684 6/20 0.34
MEN1 O00255 4/20 0.34
CYP2C19 P33261 3/20 0.34
KMT2A Q03164 3/20 0.34
HIF1A Q16665 2/20 0.34
USP2 O75604 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALOX15 P16050 1/20 0.34
S1PR1 P21453 1/20 0.34
RORC P51449 1/20 0.34
ITGB3 P05106 3/20 0.33
ITGA2B P08514 3/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12058 0.82 LIPE (0.42) LIPECYP3A4MEN1CYP2C19KMT2A
SCHEMBL11371 0.78 KCNH2 (0.34) LIPECYP3A4MEN1CYP2C19KMT2A
SCHEMBL746750 0.76 CYP3A4 (0.44) LIPECYP3A4MEN1CYP2C19KMT2A
SCHEMBL5655 0.73 CYP3A4 (0.40) CYP3A4MEN1CYP2C19KMT2AHIF1A
SCHEMBL1589024 0.73 LIPE (0.58) LIPE
SCHEMBL1589785 0.73 LIPE (0.58) LIPE
SCHEMBL1589022 0.73 LIPE (0.58) LIPE
SCHEMBL5667 0.72 CYP3A4 (0.37) CYP3A4MEN1CYP2C19KMT2AHIF1A
SCHEMBL5614 0.72 LIPE (0.60) LIPECTSBCTSSCTSK
SCHEMBL5651 0.71 LIPE (0.38) LIPECYP3A4MEN1CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed